Upload
soo
View
28
Download
0
Tags:
Embed Size (px)
DESCRIPTION
Data use for planning, implementation and evaluation of prevention, care and treatment programs for PWID in Ukraine Pavlo Smyrnov International HIV/AIDS Alliance in Ukraine. Overview. Background on HIV epidemic in Ukraine Data Action examples Peer-driven intervention (PDI) - PowerPoint PPT Presentation
Citation preview
PEPFAR
Data use for planning, implementation and evaluation of prevention, care and
treatment programs for PWID in Ukraine
Pavlo SmyrnovInternational HIV/AIDS Alliance in Ukraine
AIDS 2014 – Stepping Up The Pace
PEPFAR Overview• Background on HIV epidemic in Ukraine
• Data Action examples– Peer-driven intervention (PDI)– Risk network PDI, Outreach testing– Medication-assisted therapy (MAT)– Community-initiated treatment intervention (CITI)– Integrated care
• Conclusion
HIV epidemic among PWID in Ukraine
Kyiv
Dnipropetrovsk
Donetsk
Mykolaiv
Odesa
Lviv
AR Crimea2007 2008 2009 2011 2013
28.4%
32.8%
21.6% 21.6%
18.1%20.1%
15.0%
9.9%7.2%
3.6%
All PWID Young PWID
• Estimated # of PWID in Ukraine is 310,000• Main injectable drug of abuse – home-made acetylated poppy straw extract (opioid)• Home-made methamphetamine-type drugs are also prevalent
• HIV epidemic started in 1995 among PWID in southern and eastern regions
New cases according toAEM and Spectrum models
19901992
19941996
19982000
20022004
20062008
20102012
20142016
20182020
0
5,000
10,000
15,000
20,000
25,000
30,000
35,000
40,000
34,755
10,879
4,441
IDU Clients MSW MSMFSW Low-risk males Low-risk females
19951997
19992001
20032005
20072009
20112013
20152017
20190
5,000
10,000
15,000
20,000
25,000
30,000
35,000
40,000
22,557
9,611
1,953
IDUs FSW ClientsMSM Remaining pop
Data: Integrated Bio-Behavioral Surveys (IBBS) and Program data
2007 2008 2009 2011 20130.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
70.0%
80.0%
90.0%
100.0%
84.1%81.2% 82.6% 81.4% 83.5%
33.1%27.9%
39.4%37.0%
27.7%
IBBS: Past 30 day drug use
Opioids Stimulants
Comparison of IBBS and syringe exchange programs (SEP) data showed that not all PWID have equal access to services
– Only 20% clients of syringe exchange programs (SEP) were women
– Only 30% were teenagers and youth < 25 y.o – Only 1.5% were stimulant users
2007 2008 2009 2011 201371.0%72.0%73.0%74.0%75.0%76.0%77.0%78.0%
IBBS: % Males
2007 2008 2009 2011 201328.0
29.0
30.0
31.0
32.0
33.0
34.0
IBBS: Average age
Action: Peer Driven Intervention (PDI)
• Outreach model for reaching and educating PWID from hidden subpopulations using existing peer networks
• Recruiting coupons are used to invite peers for intervention
• IDUs are taught to share knowledge and can earn rewards for educating peers with bonuses for recruiting young IDUs and women-IDUs
Results• Starting from 2007 ~30 000 new PWID
were reached; coverage increased up to 10 times at some sites
• For most of the clients this was the first contact with harm reduction services
• Worked best with young PWID
Data: Program testing results on all PWID clients in 2011-2013
Not tested; 201506; 63%
Tested once; 81918; 26%
Tested twice or more; 32878; 10%
Error; 1166; 0%Not tested
Tested once
Tested twice or more
Error
Negative; 76,895; 93.8%
Positive; 5,023; 6.2%
Seroconverted; 798; 2.4%
Repeated negative; 32,080; 97.4%
Testing data show low yield of HIV+ in PWID clients
% positive at first test is 4.6%
(Overall prevalence is 18.6%)
Also: Preliminary data from TRIP project in Odesa suggest that in high prevalence settings up to 40% of high risk partners of HIV positive people are also HIV positive and might not be aware about their HIV status.
Action 1: Outreach testing• In the situation of radical decrease of the unit cost the scope and
attractiveness of services will also decrease and may negatively affect number of people who approach services including testing. To deal with this we prioritize outreach by social worker.
• We also propose that social workers will carry rapid tests in outreach routes and assist client in testing. This will greatly increase screening capacity (HIV detection sensitivity) of the projects as tests will be provided at time and location convenient to a client.
• In previous period the testing was limited to time schedule and physical location of doctor and nurse, many doctors were only working between 3 and 6 PM and only at NGO office location, which greatly limited accessibility of HIV testing.
Action 2: Risk Network PDI (RNPDI)
• Active recruitment of HIV positive and their risk networks. In addition to usual post-test counseling routine and referral social/outreach worker will distribute coupons and invite to take part in a survey for a small reward.
• Provide coupons to other positive clients and also for some negative at higher risk. The coupon distribution will stop once we have no more positive participants.
• This will allow actively recruit immediate risk network members of the HIV positive clients, increase screening yield and focus prevention efforts on most at risk for acquiring HIV or most likely transmitting HIV to their partners.
• This approach may increase finding of HIV cases from 4,6% up to 10% of all tested in high prevalence setting (based on data from Odesa pilot). This approach should have maximum effect in high and medium priority regions and may help to identify majority of HIV cases among high risk groups.
Data: MAT effectiveness studies
b a s e l i n e 6 m f o l l o w - u p 1 2 m f o l l o w - u p0%
10%20%30%40%50%60%70%80%90%
100%
80.50%
3.25%
4.81%
94.71%
7.66%
0.00%
home -made opioid use
buprenorphine methadone
b a s e l i n e 6 m f o l l o w - u p 1 2 m f o l l o w - u p0.00
0.05
0.10
0.15
0.20
0.25
0.300.24
0.09
0.04
0.24
0.050.03
as i drug s core
buprenorphine methadone
b a s e l i n e 6 m f o l l o w - u p 1 2 m f o l l o w - u p0%
10%
20%
30%
40%
50%
60%
70%55.24%
38.64%
17.59%
58.57%
22.98%
12.52%
de pre ss ion
buprenorphine methadone
b a s e l i n e 6 m f o l l o w - u p 1 2 m f o l l o w - u p0.000.020.040.060.080.100.120.140.160.18
0.15
0.08
0.04
0.17
0.02 0.03
b b v -t r aq in jec ti o n sc o r e
buprenorphine methadone
b a s e l i n e 6 m f o l l o w - u p 1 2 m f o l l o w - u p0.00
0.05
0.10
0.15
0.20
0.25
0.30
0.350.29
0.25
0.130.19
0.10 0.09
as i me dical s core
buprenorphine methadone
b a s e l i n e 6 m f o l l o w - u p 1 2 m f o l l o w - u p0.000.020.040.060.080.100.120.140.160.18
0.15
0.08
0.04
0.17
0.02 0.03
as i le gal s core
buprenorphine methadone
Schaub M, Chtenguelov V, Subata E, Weiler G, Uchtenhagen A (2010) Feasibility of buprenorphine and methadone maintenance programmes among users of home made opioids in Ukraine. Int J Drug Policy 21: 229-233.
Action: MAT scale-up in Ukraine
Jan/04
May/0
4
Sep/0
4
Jan/05
May/0
5
Sep/0
5
Jan/06
May/0
6
Sep/0
6
Jan/07
May/0
7
Sep/0
7
Jan/08
May/0
8
Sep/0
8
Jan/09
May/0
9
Sep/0
9
Jan/10
May/1
0
Sep/1
0
Jan/11
May/1
1
Sep/1
1
Jan/12
May/1
2
Sep/1
2
Jan/13
May/1
3
Sep/1
3
Jan/14
May/1
40
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000
Total number of MAT clients by medication
Buprenorphine, Ukraine Methadone, Ukraine
Estimated # of injecting opioid users is ~250,000
MAT covers about 3.4% of them
Crimea annexation
Data: HIV care and treatment program
2009 2010 2011 2012 20130
10,000
20,000
30,000
40,000
50,000
60,000
70,000Number of patients on ART
IDU Ukraine
PWH WI D (est )
R eg ist er ed in ca r e
Acti ve med ca r e
Ca r e a nd suppor t
R eceive AR T
R eceive AR T a t 12m*
66,960
46,872
23,436
13,000
6,007
0
163,040
85,696
42,848
52,000
49,777
47,416
Seek-test-treat-retain cascadePWID have disproportionately low access to treatment and care
*no ART retention data on PWID
Action: Community initiated treatment intervention (CITI)
• Short term rapid linkage to treatment intervention which facilitates early treatment access for active drug users.
– locate HIV positive clients in harm reduction and link them to HIV treatment using a case management approach.
– support HIV positive clients up to 6 months into ART (if no support provided through other projects - care and support, ST, integrated services)
– refer to care and support projects or other available resources for long term treatment support.
CITI is mostly focused on linkage to ART with build-in short term adherence support.
CITI preliminary data
PWH WI D (est )
R eg ist er ed in ca r e
Acti ve med ca r e
R eceive AR T
0 10,000 20,000 30,000 40,000 50,000 60,000 70,000
0 100 200 300 400 500 600 700 800 900 1,000
66,960
46,872
23,436
6,007
884
429
429
380
CITI clients All PWID
During first 3 months of CITI implementation in 2014:
• 884 clients were involved
• 429 clients registered in AIDS clinics
• 380 clients started ART• 30 clients started MAT
Conclusion:Prevention effectiveness
2005 2006 2007 2008 2009 2010 2011 2012 -
20,000
40,000
60,000
80,000
100,000
120,000
140,000
160,000
180,000
200,000
0
200
400
600
800
1000
1200
Cases among young PWID and coverage by prevention
# PWID covered by prevention# Registered cases among PWID <25 y.o.
• All data sources confirm inverse correlation between increasing coverage of prevention programs and number of new cases among PWID;
• RNPDI, rapid testing in outreach settings, CITI, and other approaches aimed at increasing the service coverage, improving PWID retention in services, and their access to care are key to the success of prevention program in Ukraine
• The effectiveness of prevention programs among PWID in reducing HIV incidence could be easily undermined in case of decreasing coverage or limiting the service package for PWID, which are inevitable in case of the anticipated decline in funding of services for PWID in Ukraine
PEPFAR
THANK YOU FOR ATTENTION!
Data: MAT retention study
Positive TB test is increasing dropout from MAT programs due to legislative requirement for inpatient treatment of active TB cases
Action: Integrated Care
• 6 sites working in TB dispensaries• 2 sites in narcological clinics pilot TB-DOTS• 1 site in narcological clinics provides ART• Implementation guidelines developed
Public Health
Tertiary
SecondaryPrimary
TB STI HIVNarco
Challenges:• Rigid vertical health
care structure• No financial incentives
for providers• Restrictive legislature